| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A modified dose calculation formalism for electronic brachytherapy sources
|
DeWerd, Larry A.
|
|
2015
|
14 |
3 |
p. 405-408
4 p.
|
article
|
| 2 |
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer
|
Mattiucci, Gian Carlo
|
|
2015
|
14 |
3 |
p. 401-404
4 p.
|
article
|
| 3 |
Commentary on “The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer”
|
Crook, Juanita
|
|
2015
|
14 |
3 |
p. 315-
1 p.
|
article
|
| 4 |
Customized vaginal vault brachytherapy with computed tomography imaging-derived applicator prototyping
|
Wiebe, Ericka
|
|
2015
|
14 |
3 |
p. 380-384
5 p.
|
article
|
| 5 |
Deformable image registration for defining the postimplant seroma in permanent breast seed implant brachytherapy
|
Hilts, Michelle
|
|
2015
|
14 |
3 |
p. 409-418
10 p.
|
article
|
| 6 |
Does prostate-specific antigen nadir predict longer-term outcomes of prostate cancer after neoadjuvant and adjuvant androgen deprivation therapy in conjunction with brachytherapy?
|
Morris, Lucinda May
|
|
2015
|
14 |
3 |
p. 322-328
7 p.
|
article
|
| 7 |
Editorial Board
|
|
|
2015
|
14 |
3 |
p. A5-
1 p.
|
article
|
| 8 |
Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy
|
Keyes, Mira
|
|
2015
|
14 |
3 |
p. 334-341
8 p.
|
article
|
| 9 |
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences
|
Tagliaferri, Luca
|
|
2015
|
14 |
3 |
p. 419-425
7 p.
|
article
|
| 10 |
From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis
|
Banerjee, Robyn
|
|
2015
|
14 |
3 |
p. 366-372
7 p.
|
article
|
| 11 |
High-dose-rate brachytherapy as a monotherapy for prostate cancer—Single-institution results of the extreme fractionation regimen
|
Kukiełka, Andrzej Marek
|
|
2015
|
14 |
3 |
p. 359-365
7 p.
|
article
|
| 12 |
Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment
|
Shaikh, T.
|
|
2015
|
14 |
3 |
p. 316-321
6 p.
|
article
|
| 13 |
Masthead
|
|
|
2015
|
14 |
3 |
p. A1-
1 p.
|
article
|
| 14 |
Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer
|
Swanick, Cameron W.
|
|
2015
|
14 |
3 |
p. 385-389
5 p.
|
article
|
| 15 |
Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy
|
Gill, Beant S.
|
|
2015
|
14 |
3 |
p. 373-379
7 p.
|
article
|
| 16 |
Refining prostate seed brachytherapy: Comparing high-, intermediate-, and low-activity seeds for I-125 permanent seed prostate brachytherapy
|
Delouya, Guila
|
|
2015
|
14 |
3 |
p. 329-333
5 p.
|
article
|
| 17 |
Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy
|
Spadinger, Ingrid
|
|
2015
|
14 |
3 |
p. 350-358
9 p.
|
article
|
| 18 |
Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity
|
Rose, Jim N.
|
|
2015
|
14 |
3 |
p. 342-349
8 p.
|
article
|
| 19 |
Table of Contents
|
|
|
2015
|
14 |
3 |
p. A3-A4
nvt p.
|
article
|
| 20 |
The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer
|
D'Alimonte, Laura
|
|
2015
|
14 |
3 |
p. 309-314
6 p.
|
article
|
| 21 |
Ultrasound use in gynecologic brachytherapy: Time to focus the beam
|
van Dyk, Sylvia
|
|
2015
|
14 |
3 |
p. 390-400
11 p.
|
article
|
Journal description